Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: In vitro models for intestinal and blood-brain barrier permeability

Planta Medica

Volumn 73, Issue 4, 2007, Pages 330-335

  Madgula, Varnsi L M ^a   Avula, Bharathi ^a   Reddy V L, Niranjan ^a   Khan, Ikhlas A ^a,b   Khan, Shabana I ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

BBB transport; Caco 2 cells; Decursin; Decursinol angelate; Intestinal transport; MDR MDCK cells

Indexed keywords

ANGELICA GIGAS EXTRACT; ATENOLOL; CAFFEINE; DECURSIN; DECURSINOL ANGELATE; LUCIFER YELLOW; PROPRANOLOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELL STRAIN; COLON CARCINOMA; CONTROLLED STUDY; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE ABSORPTION; MULTIDRUG RESISTANCE; NONHUMAN; PERMEABILITY;

ANGELICA; ANIMALS; BENZOPYRANS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-BRAIN BARRIER; BUTYRIC ACIDS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; DOGS; ENZYME ACTIVATION; HUMANS; INTESTINAL ABSORPTION; KIDNEY; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PROTEIN KINASE C;

ANGELICA GIGAS; APIACEAE;

EID: 34250362819     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-967137     Document Type: Article

References (23)

1. Clapham AR, Tutin TG, Warburg EF. Flora of British Isles. London/Cambridge: The University Press; 1952.
2. GRIN data base, National Germplasm Resources laboratory, Beltsville, Maryland. Available at http://www.arisgrin.goov/cgi-bin/npgs/html/tax_search.pl? angelica. Accessed in 2006.
3. Chi HJ, Kim HS. Studies on the components of Umbelliferae plants in Korea: pharmacological study of decursin, decursinol and nodakenin. Kor J Pharmacogn 1970; 1: 25-32.
4. Kang SY, Lee KY, Sung SH, Park MJ, Kim YC. Coumarins isolated from Angelica gigas inhibit acetyl cholinesterase: structure activity relationship. J Nat Prod 2001; 64: 683-85.
5. Lee SH, Shin DS, Kim JS, Oh KB, Kang SS. Antibacterial coumarins from Angelica gigas roots. Arch Pharm Res 2003; 26: 449-52.
6. Lee S, Lee YS, Jung SH, Shin KH, Kim BK, Kang SS. Antitumor activity of decursinol angelate and decursin from Angelica gigas. Arch Pharm Res 2003; 26: 727-30.
7. Kang SY, Lee KY, Sung SH, Kim YC. Four new neuroprotective dihydropyranocoumarins from Angelica gigas. J Nat Prod 2005; 68: 56-9.
8. Choi SS, Han KJ, Lee HK, Han EJ, Suh WH. Antinoceceptive profiles of crude extract from roots of Angelica gigas Nakai in various pain models. Biol Pharm Bull 2003; 26: 1283-88.
9. Yi W, Akoh CC, Fischer J, Krewer G. Absorption of anthocyanins from blueberry extracts by Caco-2 human intestinal epithelial cell monolayers. J Agric Food Chem 2006; 54: 5651-58.
10. Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Delivery Rev 1996; 22: 67-84.
11. Khan SI, Abourashed EA, Khan IA, Walker LA. Transport of harman alkaloids across Caco-2 cell monolayers. Chem Pharm Bull (Tokyo) 2004; 52: 394-7.
12. Khan SI, Abourashed EA, Khan IA, Walker LA. Transport of parthenolide across human intestinal cells (Caco-2). 2003; 69: 1009-12.
13. Hilgers AR, Conradi RA, Burton PS. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 1990; 7: 902-10.
14. Audus KL, Bartel RL, Hidalgo IJ, Bochardt RT. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res 1990; 7: 435-51.
15. Bohets H, Annaert P, Mannens G, Beijsterveldt L, Anciaux K, Verboven Pet al. Strategies for absorption screening in drug discovery and development. Curr Top Med Chem. 2001; 1: 367-83.
16. Gumbleton M, Audus KL. Progress and limitations in the use of in vitro cell cultures to serve as the permeability screen for the blood-brain barrier. J Pharm Sci 2001; 90: 1681-98.
17. Wang Q, Rager DJ, Weinstein K, Kardos SP, Dobson GL, Li J et al. Evaluation of the MDR-MDCK cell line as a permeability screen for the blood brain barrier. Int J Pharm 2005; 288: 349-59.
18. Lee JP, Chang SY, Park SY. Validation of analysis methods for decursin and decursinol angelate of Angelica gigants radix by reversed-phase liquid chromatography. Nat Prod Sci 2004; 10: 262-7.
19. Stewart BH, Chan OH, Lu RH, Reyner EL, Schmid HL, Hamilton BA et al. Comparision of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharm Res 1995; 12: 693-9.
20. Gres MC, Julian B, Bourrie M, Meunier V, Roques C, Berger M et al, Boulenc X. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. 1998; 15: 726-33.
21. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. 1991; 175: 880-5.
22. Camenisch G, Alsenz J, Waterbeemd H, Folkers G. Estimation of peremeability by passive diffussion through Caco-2 cell monolayers using the drugs liphophilicity and molecular weight. Eur J Pharm Sci 1998; 6: 313-9.
23. Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD et al. In vitro models for blood-brain barrier. Toxicol In Vitro 2005; 19: 299-334.